trospium chloride has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreev, MN; Darenkov, SP; Korshunov, DM; Korshunov, MN; Korshunova, ES; Pyatnitskaya, TM; Suponeva, NA | 1 |
| Krivoborodov, GG; Mazo, EB | 1 |
1 review(s) available for trospium chloride and Parkinson Disease
| Article | Year |
|---|---|
[Neurological aspect of the hyperactive urinary bladder syndrome].
Topics: Benzilates; Brain; Brain Diseases; Cerebrovascular Circulation; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic | 2005 |
1 other study(ies) available for trospium chloride and Parkinson Disease
| Article | Year |
|---|---|
[Long-term safety and efficacy of trospium chloride for the treatment of neurogenic overactive bladder due to Parkinson's disease is there an effect on cognitive status?]
Topics: Benzilates; Humans; Middle Aged; Nortropanes; Parkinson Disease; Quality of Life; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2022 |